TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32628266

Group type: EXPERIMENTAL
Intervention: Rivaroxaban, 15 mg/d
Number of subjects: 7213

Group type: COMPARATOR
Intervention: Aspirin, 100 mg/d
Number of subjects: 7213

Group type: EXPERIMENTAL
Intervention: Atrial fibrillation
Number of subjects: 7213

Group type: EXPERIMENTAL
Intervention: Location of infarct
Number of subjects: 7213
Study: 34854342

Group type: EXPERIMENTAL
Intervention: Mindfulness training (Mindfulness‐Acceptance‐Commitment programme for 7 weeks)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 45
Study: 32901316

Group type: EXPERIMENTAL
Intervention: Intrathecal rituximab (25 mg every 6 months)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Intrathecal rituximab
Number of subjects: 14
Study: 35758724

Group type: EXPERIMENTAL
Intervention: Clarke score
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Continuous glucose monitoring (CGM) measures of hypoglycemia exposure
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Composite threshold of IAH-Clarke ≥4 with ROC curve-derived thresholds for CGM measures of hypoglycemia exposure
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Metrics for predicting defective glucose counterregulation by the EGP response
Number of subjects: 43
Study: 32764462

Group type: EXPERIMENTAL
Intervention: high lycopene + low lutein (HLyLLu)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: high lycopene + high lutein (HLyHLu)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: low lycopene + high lutein (LLyHLu)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: low lycopene + low lutein (LLyLLu)
Number of subjects: 28
Study: 33582402

Group type: EXPERIMENTAL
Intervention: Identified risk factors regarding child protection referrals of unborn babies
Number of subjects: 338

Group type: EXPERIMENTAL
Intervention: Drug use, alcohol use, age, antenatal care attendance, mental wellbeing, domestic violence, childhood experiences
Number of subjects: 338

Group type: COMPARATOR
Intervention: Midwives and social workers
Number of subjects: 338
Study: 32186107

Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA) plus methotrexate (MTX) + leflunomide (LEF)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Acupuncture plus MTX + LEF
Number of subjects: 60

Group type: COMPARATOR
Intervention: Methotrexate (MTX) + leflunomide (LEF) (Control group)
Number of subjects: 60
Study: 35774017

Group type: EXPERIMENTAL
Intervention: Catheter‐based thrombus removal (CBTR)
Number of subjects: 48
Study: 34344360

Group type: EXPERIMENTAL
Intervention: Circulating long chain acylcarnitines (LCAC) levels in heart failure patients with diabetes mellitus (DM)
Number of subjects: 664

Group type: EXPERIMENTAL
Intervention: Circulating long chain acylcarnitines (LCAC) levels in heart failure patients without diabetes mellitus (DM)
Number of subjects: 664

Group type: EXPERIMENTAL
Intervention: Change in LCAC levels after exercise in heart failure patients with diabetes mellitus (DM)
Number of subjects: 664

Group type: EXPERIMENTAL
Intervention: Change in LCAC levels after exercise in heart failure patients without diabetes mellitus (DM)
Number of subjects: 664

Group type: EXPERIMENTAL
Intervention: Time to primary clinical outcome in heart failure patients with diabetes mellitus (DM)
Number of subjects: 664

Group type: EXPERIMENTAL
Intervention: Time to primary clinical outcome in heart failure patients without diabetes mellitus (DM)
Number of subjects: 664

Group type: EXPERIMENTAL
Intervention: Individual metabolites (C16, C16:1, C18, C18:1) in heart failure patients
Number of subjects: 664

Group type: COMPARATOR
Intervention: Control group of patients without heart failure from the CATHGEN study
Number of subjects: 664
Study: 35473736

Group type: EXPERIMENTAL
Intervention: Orthodontic treatment
Number of subjects: 98

Group type: COMPARATOR
Intervention: Adenotonsillectomy (AT)
Number of subjects: 98
Study: 34977534

Group type: EXPERIMENTAL
Intervention: Digital Exercise Therapy Application (DETA)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional Physical Therapy (PT)
Number of subjects: 60
Study: 32213768

Group type: EXPERIMENTAL
Intervention: Na2FPO3/CaCO3 fluoride toothpaste (1,378 µg F/g total soluble fluoride)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Aged fluoride toothpaste (1,160 µg F/g total soluble fluoride)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Aged fluoride toothpaste (900 µg F/g total soluble fluoride)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Aged fluoride toothpaste (597 µg F/g total soluble fluoride)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Non-fluoride placebo toothpaste
Number of subjects: 10
Study: 33043775

Group type: EXPERIMENTAL
Intervention: AC discordance
Number of subjects: 236

Group type: EXPERIMENTAL
Intervention: sEFW discordance
Number of subjects: 236
Study: 33302871

Group type: EXPERIMENTAL
Intervention: TeamCare (TC) - blended collaborative care for 12 months
Number of subjects: 440

Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 440
Study: 34240669

Group type: EXPERIMENTAL
Intervention: Resistance training (15 weeks, 3 times per week)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Control group (untreated)
Number of subjects: 65
Study: 33722403

Group type: COMPARATOR
Intervention: Enalapril + Losartan (Group A)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Enalapril + Losartan + Amiloride (Group B)
Number of subjects: 31
Study: 34058419

Group type: EXPERIMENTAL
Intervention: Steroid group
Number of subjects: 2331

Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 2331

Group type: EXPERIMENTAL
Intervention: Both groups (steroid and placebo)
Number of subjects: 2331

Group type: EXPERIMENTAL
Intervention: Prior pregnancy with neonatal respiratory morbidity
Number of subjects: 2331
Study: 34688506

Group type: EXPERIMENTAL
Intervention: Remote SafERteens
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: In-person SafERteens
Number of subjects: 122

Group type: COMPARATOR
Intervention: Enhanced Usual Care (EUC)
Number of subjects: 122
Study: 33145642

Group type: EXPERIMENTAL
Intervention: Otelixizumab 9 mg
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Otelixizumab 18 mg
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Otelixizumab 27 mg
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Otelixizumab (all doses)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 32394438

Group type: EXPERIMENTAL
Intervention: Psychotherapy and fasting-mimicking diet
Number of subjects: 20

Group type: COMPARATOR
Intervention: Psychotherapy only
Number of subjects: 20
Study: 33662243

Group type: EXPERIMENTAL
Intervention: Animal Assisted Therapy (AAT) with an emotional support canine in the child's lap
Number of subjects: 47

Group type: COMPARATOR
Intervention: Control group (no animal assisted therapy)
Number of subjects: 47
Study: 33168129

Group type: EXPERIMENTAL
Intervention: Home treatment (HT) during the RCT study phase
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Home treatment (HT) under routine care conditions
Number of subjects: 0

Group type: COMPARATOR
Intervention: Hospital ward treatment
Number of subjects: 0
Study: 36191758

Group type: EXPERIMENTAL
Intervention: CordellaTM PAP Sensor
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard-of-care control arm
Number of subjects: 0
Study: 34520941

Group type: EXPERIMENTAL
Intervention: Supervisory neglect
Number of subjects: 11208

Group type: EXPERIMENTAL
Intervention: Qualitative review of 150 cases
Number of subjects: 11208

Group type: EXPERIMENTAL
Intervention: Child exposure to domestic violence
Number of subjects: 11208

Group type: EXPERIMENTAL
Intervention: Caregiver's substance-related problems
Number of subjects: 11208

Group type: EXPERIMENTAL
Intervention: Co-occurrence of factors
Number of subjects: 11208
Study: 32213899

Group type: EXPERIMENTAL
Intervention: Casein hydrolysate (5 g)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 34698342

Group type: EXPERIMENTAL
Intervention: Free distribution of oral rehydration salts (ORS) via home deliveries prior to diarrhoea onset
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Free distribution via vouchers
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Door-to-door sales model
Number of subjects: 4

Group type: COMPARATOR
Intervention: Control arm (normal activities by CHWs)
Number of subjects: 4
Study: 34130906

Group type: EXPERIMENTAL
Intervention: Behavioral Activation (BA)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Friendly Visits
Number of subjects: 64
Study: 32764872

Group type: EXPERIMENTAL
Intervention: Collagenase Clostridium histolyticum (CCH) 0.58 mg
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study: 36122258

Group type: EXPERIMENTAL
Intervention: Nefopam (20 mg over 30 minutes, continuous infusion for 24 hours)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Normal saline (same volume as nefopam solution, administered in the same manner)
Number of subjects: 90
Study: 32237208

Group type: EXPERIMENTAL
Intervention: Computer-aided learning for managing stress (CALMS) integrated with family therapy for 12 weeks
Number of subjects: 11
Study: 33040101

Group type: EXPERIMENTAL
Intervention: Cognitive behaviour therapy (20 weekly sessions)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 30
Study: 36070117

Group type: EXPERIMENTAL
Intervention: Tarsofrontalis sling surgery using silicon rod
Number of subjects: 44

Group type: COMPARATOR
Intervention: Supramaximal levator resection
Number of subjects: 44
Study: 34425501

Group type: EXPERIMENTAL
Intervention: Medical cannabis/cannabis-based medicine (MC/CBM)
Number of subjects: 0
Study: 32915972

Group type: EXPERIMENTAL
Intervention: 10-day decitabine combined with ibrutinib (560 mg; sequentially given, starting the day after the last dose of decitabine) (n = 72)
Number of subjects: 144

Group type: COMPARATOR
Intervention: 10-day decitabine (n = 72)
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Both arms (decitabine plus ibrutinib and decitabine)
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Decitabine plus ibrutinib
Number of subjects: 144
Study: 34496274

Group type: EXPERIMENTAL
Intervention: Picture-taking feature of the food diary app
Number of subjects: 0

Group type: COMPARATOR
Intervention: No picture-taking feature (control)
Number of subjects: 0
Study: 34250945

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioural Therapy (CBT)
Number of subjects: 255

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 255
Study: 32031096

Group type: EXPERIMENTAL
Intervention: ProTaper Next group (continuous rotary system)
Number of subjects: 60

Group type: COMPARATOR
Intervention: WaveOne group (reciprocating instruments)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 60
Study: 34432263

Group type: EXPERIMENTAL
Intervention: Personalised online functional imagery training (FIT) over 2 weeks
Number of subjects: 52

Group type: COMPARATOR
Intervention: Standard risk information about binge drinking at university (Control)
Number of subjects: 52
Study: 32187119

Group type: EXPERIMENTAL
Intervention: MBSR+
Number of subjects: 98

Group type: COMPARATOR
Intervention: SMH
Number of subjects: 98
Study: 36215061

Group type: EXPERIMENTAL
Intervention: Meditation training
Number of subjects: 137

Group type: COMPARATOR
Intervention: Non-native language training
Number of subjects: 137

Group type: COMPARATOR
Intervention: No intervention
Number of subjects: 137
Study: 32931712

Group type: EXPERIMENTAL
Intervention: Pharmacist-led educational intervention
Number of subjects: 916

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 916
Study: 32822676

Group type: EXPERIMENTAL
Intervention: Low dose CT (CT) screening
Number of subjects: 449

Group type: COMPARATOR
Intervention: Chest radiography (CXR) screening
Number of subjects: 449

Group type: COMPARATOR
Intervention: SEER cohort (general population)
Number of subjects: 449

Group type: EXPERIMENTAL
Intervention: CT arm
Number of subjects: 449

Group type: EXPERIMENTAL
Intervention: Primary tumor size below median of 17 mm
Number of subjects: 449

Group type: EXPERIMENTAL
Intervention: Limited resection vs. full resection
Number of subjects: 449

Group type: EXPERIMENTAL
Intervention: Nonsurgical treatment vs. full resection
Number of subjects: 449
Study: 36316826

Group type: EXPERIMENTAL
Intervention: Probiotic formulation with 3 billion CFU (Lactobacillus acidophilus, Bifidobacterium bifidum, Lactobacillus rhamnosus)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Probiotic formulation with 8 billion CFU (Lactobacillus acidophilus, Bifidobacterium bifidum, Lactobacillus rhamnosus, Lactobacillus paracasei, Bifidobacterium longum, Bifidobacterium lactis, Lactobacillus casei, Bifidobacterium animallis)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 32943750

Group type: EXPERIMENTAL
Intervention: Lomustine in combination with idarubicin and cytarabine
Number of subjects: 330

Group type: COMPARATOR
Intervention: Conventional chemotherapy without lomustine
Number of subjects: 330
Study: 35000532

Group type: EXPERIMENTAL
Intervention: Swallowing sparing intensity modulated radiotherapy (SW‐IMRT)
Number of subjects: 146

Group type: COMPARATOR
Intervention: Standard parotid sparing intensity-modulated radiotherapy (ST‐IMRT)
Number of subjects: 146
Study: 35361026

Group type: EXPERIMENTAL
Intervention: Dexamethasone (8 mg tds for days 1-7, then 8 mg od for days 8-21)
Number of subjects: 334

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 334
Study: 32752178

Group type: EXPERIMENTAL
Intervention: Lactobacillus plantarum PS128 supplementation (LG, 3 × 10^10 CFU/day)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo group (PG)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lactobacillus plantarum PS128 supplementation (LG)
Number of subjects: 0
Study: 35685605

Group type: EXPERIMENTAL
Intervention: Alvogyl
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: mixture of Nigella sativa's powder and oil
Number of subjects: 60

Group type: COMPARATOR
Intervention: control
Number of subjects: 60
Study: 33260268

Group type: EXPERIMENTAL
Intervention: Medical treatments
Number of subjects: 557

Group type: EXPERIMENTAL
Intervention: Psychological treatments
Number of subjects: 557

Group type: EXPERIMENTAL
Intervention: Self-help strategies
Number of subjects: 557

Group type: EXPERIMENTAL
Intervention: Medicines
Number of subjects: 557
Study: 33687180

Group type: EXPERIMENTAL
Intervention: Mechanical insufflation/exsufflation (MI/E) with expiratory flow accelerator (EFA) technology
Number of subjects: 30

Group type: COMPARATOR
Intervention: Mechanical insufflation/exsufflation (MI/E) only
Number of subjects: 30

Group type: COMPARATOR
Intervention: Both groups (EFA and MI/E only)
Number of subjects: 30
Study: 33047455

Group type: EXPERIMENTAL
Intervention: TDF 300 mg every 48 hours
Number of subjects: 46

Group type: COMPARATOR
Intervention: TDF 300 mg every 72 hours
Number of subjects: 46
Study: 32791677

Group type: EXPERIMENTAL
Intervention: Video-guided educational technology intervention
Number of subjects: 60

Group type: COMPARATOR
Intervention: Care-as-usual control group
Number of subjects: 60
Study: 33449095

Group type: EXPERIMENTAL
Intervention: Aspirin use at least 3 times/week
Number of subjects: 139896

Group type: EXPERIMENTAL
Intervention: Any aspirin use
Number of subjects: 139896

Group type: COMPARATOR
Intervention: Aspirin use
Number of subjects: 139896
Study: 32907456

Group type: EXPERIMENTAL
Intervention: Suture Button (SB)
Number of subjects: 113

Group type: COMPARATOR
Intervention: Syndesmotic Screw (TS)
Number of subjects: 113
Study: 35660440

Group type: EXPERIMENTAL
Intervention: Continuous no-till (NT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Chisel-disk (CD)
Number of subjects: 0
Study: 34154394

Group type: EXPERIMENTAL
Intervention: Fluoxetine
Number of subjects: 93

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 93
Study: 35604746

Group type: EXPERIMENTAL
Intervention: In-person, office-based bCBCT (OB-bCBCT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Home-based telehealth bCBCT (HB-bCBCT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: In-person psychoeducation comparison condition (PTSD family education [OB-PFE])
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: All treatments (OB-bCBCT, HB-bCBCT, OB-PFE)
Number of subjects: 0
Study: 32382083

Group type: EXPERIMENTAL
Intervention: A‐CHOP (Alemtuzumab plus CHOP)
Number of subjects: 116

Group type: COMPARATOR
Intervention: CHOP (Control)
Number of subjects: 116
Study: 35984171

Group type: EXPERIMENTAL
Intervention: Circuit training with low-carbohydrate diet (CTE + LC diet)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Circuit training (CTE)
Number of subjects: 70
Study: 34467636

Group type: EXPERIMENTAL
Intervention: Suchana intervention
Number of subjects: 0
Study: 32867982

Group type: EXPERIMENTAL
Intervention: Thymol
Number of subjects: 2000

Group type: EXPERIMENTAL
Intervention: Carvacrol
Number of subjects: 2000

Group type: EXPERIMENTAL
Intervention: Euganol
Number of subjects: 2000

Group type: COMPARATOR
Intervention: Control (without EOs)
Number of subjects: 2000
Study: 36053286

Group type: EXPERIMENTAL
Intervention: Direct-to-consumer-style PRS report for 5 common complex conditions
Number of subjects: 84

Group type: COMPARATOR
Intervention: Control information
Number of subjects: 84
Study: 35096758

Group type: EXPERIMENTAL
Intervention: Nomogram for predicting cancer-specific survival (CSS)
Number of subjects: 3172

Group type: EXPERIMENTAL
Intervention: Nomogram for predicting CSS
Number of subjects: 3172
Study: 35778479

Group type: EXPERIMENTAL
Intervention: 20 mL of coconut oil/day
Number of subjects: 44

Group type: COMPARATOR
Intervention: Diet therapy
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Diet therapy and 20 mL of coconut oil/day
Number of subjects: 44
Study: 34872303

Group type: EXPERIMENTAL
Intervention: Fu's subcutaneous needling (FSN) therapy
Number of subjects: 60

Group type: COMPARATOR
Intervention: Massage therapy
Number of subjects: 60
Study: 32464832

Group type: EXPERIMENTAL
Intervention: Pirfenidone
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study: 33693552

Group type: COMPARATOR
Intervention: COVID-19 vaccines
Number of subjects: 0
Study: 33465369

Group type: EXPERIMENTAL
Intervention: IVUS-guided DK crush stenting
Number of subjects: 556

Group type: COMPARATOR
Intervention: Angiography-guided DK crush stenting
Number of subjects: 556
Study: 32885298

Group type: EXPERIMENTAL
Intervention: Post-CCRT ADC50
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Pre-CCRT delineation and feature repeatability
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Post-CCRT repeatability
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: All features except for T2WKurtosis
Number of subjects: 58
Study: 32078966

Group type: EXPERIMENTAL
Intervention: Combined CBT and sertraline
Number of subjects: 319

Group type: COMPARATOR
Intervention: Cognitive behavioral therapy (CBT)
Number of subjects: 319

Group type: COMPARATOR
Intervention: Pharmacotherapy (sertraline)
Number of subjects: 319

Group type: COMPARATOR
Intervention: Pill placebo
Number of subjects: 319
Study: 33279734

Group type: EXPERIMENTAL
Intervention: Public insurance or uninsured status
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Experience of intimate partner violence
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Greater number of living children
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Younger maternal age
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Greater number of pregnancies
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Transportation difficulties
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lack of insurance and public insurance
Number of subjects: 0
Study: 33376568

Group type: EXPERIMENTAL
Intervention: Immediate injections of rocuronium after propofol administration (Group PRi)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Delayed rocuronium injections when BIS decreased to <60 after propofol administration (Group PRd)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Both groups (PRi and PRd)
Number of subjects: 100
Study: 34076892

Group type: EXPERIMENTAL
Intervention: PREPARE website plus an easy-to-read advance directive (AD)
Number of subjects: 986

Group type: COMPARATOR
Intervention: AD only
Number of subjects: 986

Group type: EXPERIMENTAL
Intervention: Both arms (PREPARE and AD only)
Number of subjects: 986
Study: 32858313

Group type: EXPERIMENTAL
Intervention: Rumination
Number of subjects: 119

Group type: COMPARATOR
Intervention: Control condition (not specified)
Number of subjects: 119
Study: 35871088

Group type: EXPERIMENTAL
Intervention: Videoconferencing delivered cognitive behavior therapy (VCBT) weekly over a 10-week period
Number of subjects: 78

Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 78
Study: 33762635

Group type: EXPERIMENTAL
Intervention: Substance use alone (Subs)
Number of subjects: 3914

Group type: EXPERIMENTAL
Intervention: Psychiatric symptomatology alone (Psych)
Number of subjects: 3914

Group type: EXPERIMENTAL
Intervention: Comorbidity (Com)
Number of subjects: 3914

Group type: EXPERIMENTAL
Intervention: Brain meQTL of the Subs-associated SNPs
Number of subjects: 3914

Group type: EXPERIMENTAL
Intervention: Brain meQTL of the Psych-associated SNPs
Number of subjects: 3914
Study: 33139629

Group type: EXPERIMENTAL
Intervention: Low Fermentable Oligo‐, Di‐and Mono‐saccharides And Polyols (FODMAP) Diet (LFD)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Gluten Free Diet (GFD)
Number of subjects: 0
Study: 35560631

Group type: EXPERIMENTAL
Intervention: Fasted condition (24-hrs postprandial)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Fed condition (3-hrs postprandial)
Number of subjects: 18
Study: 33984593

Group type: EXPERIMENTAL
Intervention: Fuzheng Jiedu Xiaoji formulation (FZJDXJ) combined with TACE
Number of subjects: 291

Group type: COMPARATOR
Intervention: Standard treatment alone (Control)
Number of subjects: 291
Study: 32652307

Group type: EXPERIMENTAL
Intervention: Fork-tip needle
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: Franseen needle
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: Stylet retraction
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: No suction
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: Pancreatic mass larger than 3 cm
Number of subjects: 129
Study: 34496619

Group type: EXPERIMENTAL
Intervention: Alteplase (treated group in MaRISS)
Number of subjects: 1736

Group type: COMPARATOR
Intervention: No alteplase (non-treated group in MaRISS)
Number of subjects: 1736

Group type: COMPARATOR
Intervention: PRISMS (randomized group)
Number of subjects: 1736